Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5355_Библиотеки_им_академика_М_И_Перельмана
.pdf
TABLE 1.1 (Continued)
https://t.me/med1917
Work Done on 3D- printed Drug Delivery Systems
S.No Drug Technology Formulation Excipients Parameters Studied
17. Progesterone (Salmoria
et al., 2012)
18. Paracetamol or 4- ASA
(Alruwaili et al., 2018)
19. Ibuprofen (Martinez et
al., 2017)
20. Salicylic acid (Goyanes
et al., 2016)
21. Guaifenesin (Khaled et
al., 2014)
22. Pseudoephedrine
(Jassim- Jaboori and
Oyewumi, 2015)
23. Nifedipine, captopril,
and Glipizide (Khaled
et al., 2015)
SLS Drug- delivery
device
PCL (Molar mass around 70,000– 90,000
g/ mol, the melting temperature of 60
°C and melt ow rate 1.00 g/ 10 min).
The particles size was 150– 212µm)
SLA Tablets Polyethylene glycol diacrylate (PEGDA),
PEG 300 and diphenyl (2,4,6- trimethyl
benzoyl)phosphine oxide
SLA Hydrogels PEGDA, PEG 300, diphenyl (2,4,6-
trimethyl benzoyl)phosphine oxide or
riboavin and triethanolamine
SLA, FDM Nose mask
Patches
Desktop 3D
Tablet HPMC 2910, SSG type A, MCC PH 102 Weight uniformity, hardness,
PEGDA, PEG 300, diphenyl (2,4,6-
trimethyl benzoyl)phosphine oxide
printer
A laboratory-
scale 3DP
machine
Capsule Eudragit® E- 100 (Rohm Pharma.
Average molecular weight of 150,000
and is soluble below pH 5 and
permeable above pH 5) and ethanol
3D extrusion
printing
Tablet PEG 6000, (HPMC 2910)
(hypromellose®), sodium chloride 99
%, and tromethamine USP grade.
D- mannitol 99 %, Croscarmellose
sodium (CCS) (Primellose®), MCC
(Pharmacel® 102) and sodium starch
glycolate (SSG) (Primojel®), HPMC
K100MCR) (Methocel TM), Milli- Q
water (resistivity 18.2 MΩ cm)
Drug loading efciency, mass loss of
the reservoirs of PCL, functional
drug delivery for gradient reservoirs
of the PCL with progesterone
Drug release
Drug content, swelling ratio, and
water content, dissolution study
Drug- loading diffusion test
friability
Hardness, friability
In vitro drug dissolution, content
uniformity
weight variation
14
Handbook of 3D Printing in Pharmaceutics
https://t.me/med1917
24. Acetaminophen (Khaled
et al., 2015)
25. Cinnarizine (Singhet al.,
2021)
26. Acetaminophen (Zhang
et al., 2019)
27. Baclofen (Abdulkhaleq
et al., 2023)
28. Verapamil hydrochloride
(Qian et al., 2022)
29. Ketorolac (Khan et al.,
2022)
3DP technology Capsule shell PVA, 5– 25% HPMC Dissolution test
FDM Tablet PVA Melting point, loss on drying
weight variation, friability
hardness, drug content
Hot melt
extrusion
Cellulose-
based
laments
Hypromellose acetate succinate, HPMC,
HPC, EC
Thermogravimetric analysis,
differential scanning calorimetry
(DSC)
polarized light microscopy (PLM)
Repka- Zhang test of the mechanical
properties of laments, Fourier-
transform infrared spectroscopy
(FTIR), XRPD, rheology analysis,
tablet morphology, tablet strength,
in vitro drug release
Hot melt
extrusion and
FDM
Gastro-
oating
drugdelivery
dosage form
Eudragit RS- 100 and EC Drug content, in vitro oating
behavior, in vitro dissolution,
DSC, FT- IR,
in vivo radiographic study, weight
variation,
tablet
FDM Sustained-
release
gastricoating
Pneumatic- based
microextrusion
Oral Thin
Films
printing
technology
(Afnisol™ HPMC HME 100lv),
Polyvinyl caprolactam- polyvinyl
acetate- polyethylene glycol
copolymer, PEG, Methanol
HPC, starch, carbopol, HPMC,
Propylene glycol, BHA, BHP, vitamin
E, acetate, sunset yellow, puried
water
Weight, hardness, drug content
Viscosity, density, spreadability,
moisture content tensile strength,
disintegration, dissolution,
uniformity of dosage
(continued)
newgenrtpdf
Advancements in Tailoring Medication
15
https://t.me/med1917
TABLE 1.1 (Continued)
Work Done on 3D- printed Drug Delivery Systems
S.No Drug Technology Formulation Excipients Parameters Studied
30. Rivaroxaban (Shkara et
al., 2022)
31. Catechin (Tagami et al.,
2019)
32. Paclitaxel and rapamycin
(Serris et al., 2020)
33. Paracetamol (RodríguezPombo et al., 2023)
34. Metronidazole (Utomo et
al., 2022)
Fused deposition
modeling 3DP
technique
Semi- solid
extrusion- type
3D printer
Hot melt
extrusion
Tomographic
volumetric 3D
printing
Semi- solid
extrusion
Tablet Kollidon® VA 64 (Vinylpyrrolidone-
vinyl acetate copolymer), Soluplus®
(polyvinyl caprolactampolyvinyl
Drug content, in vitro drug- release
test, hardness
friability
acetate- polyethylene glycol
graft copolymer), Kollidon®
30 (Polyvinylpyrrolidone
K30), and Kollidon® 12 PF
(Polyvinylpyrrolidone K12),
PEG 400, PEG 4000, and Mannitol,
Poloxamer 407, Sodium starch
glycolate and Croscarmellose sodium
Muco-
Adhesive
oral lms
HPMC (METOLOSE 90SH- 15000SR
HPMC 2208 type), Mannitol, Tween
20, Tween 80, glycerol and ethanol
Dissolution test, viscosity, lm
weight and thickness
PLGA Films PLGA In vitro drug- release kinetics
Printlets PEGDA, PEG, distilled water, lithium
Absorbance
phenyl 246 trimethyl benzoyl
phoshilate, isopropanol, acetonitrile
199.9% HPLC grade, methanol HPLC
grade
Intravaginal
devices
PCL copolymer of methyl vinyl ether
and maleic anhydride
FTIR, SEM, thermal analysis,
rheology, swelling kinetic
measurements, bioadhesion tests
on porcine skin.
newgenrtpdf
16
Handbook of 3D Printing in Pharmaceutics
35. Carbamazepine (Hu et
https://t.me/med1917
al., 2023)
36. Paracetamol (Domsta et
al., 2022)
37. Lidocaine (Chatzitaki T
et al., 2021)
38. Budesonide and
Tofacitinib citrate
(Awad et al., 2023)
Semi- solid
extrusion
Molding
technique
Pressure assisted
microsyringes
technology
Semi- solid
extrusion
Tablet SSG, PVP K30 Hardness, disintegration time,
friability
Suppositories PEG, hard fat Breaking force, uniformity of mass,
diameter, and drug content, drugrelease studies
Suppositories
(SNEDDS)
GeloilTM SC, Gelucire48/ 16, Kolliphor
RH40
DSC, PXRD, FTIR, SEM, TEM
disintegration time, selfemulsication time, droplet size &
zeta potential drug loading, in vitro
drug release
Suppositories Gelucire 44/ 14, coconut oil, N,
Disintegration, dissolution
N- Dimethylacetamide
Advancements in Tailoring Medication
17
https://t.me/med1917
18
Handbook of 3D Printing in Pharmaceutics
scientists are working on formulation development approaches using 3DP to meet
patient needs. The domain of medical devices, prosthetics, implants, dentures, surgical accessories, regenerative medicine and tissue/ organ fabrication have seen the
utility value of 3DP technology for tailoring individual patient needs. Despite the signicant advancements in medicine delivery facilitated by 3DP technology, there are
numerous obstacles that necessitate careful consideration. Some factors comprise the
type of AM technology suitable, the printing rate, the speed of the printing head,
the time interval allocated to print each layer, selection of the polymer material
for the printing process. In addition to the challenges inherent in the printing process,
the cost of product development and the lack of built- in exibility pose signicant
concerns in the context of 3D printing. From a manufacturing perspective and technique employed, a comprehensive understanding of various factors is necessary, for
example, the powder rate of the binder liquid, the interaction between the binder
and the powder, the processes of re- solidication and evaporation, as well as the
dissolving of the powder. The troubleshooting varies with each material and method
employed and the product in consideration for printing, especially pharmaceuticals
where the stability of the drug candidate is important. As technology advances, the
potential applications of 3DP in healthcare are likely to expand. The existing lacunae
would be overcome leading to more innovative approaches for delivering healthcare
services.
REFERENCES
Abdulkhaleq, N.M. and Ghareeb, M.M. 3D printing of baclofen gastro- oating drug delivery
systems: a comparison study with in vitro and in vivo evaluation. Research Journal of
Pharmacy and Technology 16(1) (2023) 363– 72. doi: 10.52711/ 0974- 360X.2023.00063.
Adamo, A., Beingessner, R.L., Behnam, M., Chen, J., Jamison, T.F. and Jensen, K.F. On-
demand continuous- ow production of pharmaceuticals in a compact, recongurable
system. Science, 352 (2016) 61– 67.
Agarwal, S., Saha, S., Balla, V.K., Pal, A., Barui, A. and Bodhak S. Current developments in
3D bioprinting for tissue and organ regeneration – a review. Frontiers in Mechanical
Engineering, 6 (2020) 589171.
Alhijjaj, M., Belton, P. and Qi, S. An investigation into the use of polymer blends to improve the
printability of and regulate drug release from pharmaceutical solid dispersions prepared
via fused deposition modeling (FDM) 3D printing. European Journal of Pharmaceutics
and Biopharmaceutics, 108 (2016) 111– 125.
Alhnan, M.A., Okwuosa, T.C., Sadia, M., Wan, K.W., Ahmed, W. and Arafat, B. Emergence
of 3D printed dosage forms: opportunities and challenges. Pharmaceutical Research, 33
(2016) 1817– 1832.
Ameeduzzafar, Alruwaili, N.K., Rizwanullah, M., Abbas Bukhari, S.N., Amir, M., Masood
Ahmed, M. and Fazil, M. 3D printing technology in design of pharmaceutical products.
Current Pharmaceutical Design, 24 (2018) 5009– 5018.
Angeliki, S., Eleni,T., Rekkas D.M. and Marilena, V. 3D- printed modied- release tablets: a
review of the recent advances. Molecular Pharmacology Intech Open, London, 2020.
www.int echo pen.com/ chapt ers/ 70777
Awad, A., Fina, F., Treneld, S.J., Patel, P., Goyanes, A. and Gaisford, S. 3D printed
pellets (miniprintlets): a novel, multi- drug, controlled release platform technology.
Pharmaceutics, 11 (2019) 148.
https://t.me/med1917
Advancements in Tailoring Medication
Awad, A., Hollis, E., Goyanes, A., Orlu, M., Gaisford, S. and Basit, A.W. 3D printed multi-
19
drug- loaded suppositories for acute severe ulcerative colitis. International Journal of
Pharmaceutics: X, 5(2023) 100165. https:// doi.org/ 10.1016/ j.ijpx.2023.100 165
Awad, A., Madla, C.M., McCoubrey, L.E., Ferraro, F., Gavins, F.K., Buanz, A., Gaisford, S.,
Orlu, M., Siepmann, F., Siepmann, J. and Basit, A.W. Clinical translation of advanced
colonic drug delivery technologies. Advanced Drug Delivery Reviews, 1 (2022)
114076.
Bácskay, I., Ujhelyi, Z., Fehér, P. and Arany, P. The evolution of the 3D- printed drug delivery
systems: a Review. Pharmaceutics, 14(7) (2022) 1312. https:// doi.org/ 10.3390/ pharma
ceut ics1 4071 312
Barazanchi, A., Li, K.C., Al- Amleh, B., Lyons, K. and Waddell, J.N. Additive technology: update
on current materials and applications in dentistry. Journal of Prosthodontics, 26 (2017)
156– 163.
Baylón, K., Rodríguez- Camarillo, P., Elías- Zúñiga, A., Díaz- Elizondo, J.A., Gilkerson, R.
and Lozano, K. Past, present and future of surgical meshes: a review. Membranes, 7
(2017) 47.
Biglino, G., Hopfner, C., Lindhardt, J., et al. Perspectives on medical 3D printing at the point-
of- care from the new European 3D Printing Special Interest Group, 3D Printing in
Medicine, 9(1) (2023) 14.
Calvo- Haro, J.A., Pascau, J., Asencio- Pascual, J.M., et al. Point- of- care manufacturing: a
single university hospital’s initial experience. 3D Printing in Medicine, 7(1) (2021) 11.
https:// doi.org/ 10.1186/ s41 205- 021- 00101- z
Calvo- Haro, J.A., Pascau, J., Mediavilla- Santos, L., Sanz- Ruiz, P., Sánchez- Pérez, C., Vaquero-
Martín, J. and Perez- Mañanes, R. Conceptual evolution of 3D printing in orthopedic
surgery and traumatology: from “do it yourself” to “point of care manufacturing”. BMC
Musculoskeletal Disorders, 22(1) (2021 Dec) 360.
Caudill, C.L., Perry, J.L., Tian, S., Luft, J.C. and DeSimone, J.M. Spatially controlled coating
of continuous liquid interface production microneedles for transdermal protein delivery.
Journal of Controlled Release, 284 (2018) 122– 132.
Chatzitaki, A.T., Tsongas, K., Tzimtzimis, E.K., Tzetzis, D., Bouropoulos, N., Barmpalexis, P.,
Eleftheriadis, G.K., Fatouros, D.G. 3D printing of patient- tailored SNEDDS- based suppositories of lidocaine. Journal of Drug Delivery Science Technology, 61(2021) 102292.
https:// doi.org/ 10.1016/ j.jddst.2020.102 292
Choi, Y.W., Ryoo, B.H. and Jeong, Y.M. Novel controlled release- niacin formulation. Google
Patents (2009).
Cox, S.C., Jamshidi, P., Eisenstein, N.M., Webber, M.A., Hassanin, H. and Attallah, M.M.
Adding functionality with additive manufacturing: fabrication of titanium- based antibiotic eluting implants. Materials Science and Engineering C, 64 (2016) 407– 415.
Di Marzio, N., David, E., Tiziano, S. and Lorenzo M. Bio- fabrication: Convergence of
3D bioprinting and nano- biomaterials in tissue engineering and regenerative medicine. Frontiers in Bioengineering and Biotechnology, 8(2020), 326. doi: 10.3389/
fbioe.2020.00326
Domsta, V., Krause, J., Weitschies, W. and Seidlitz, A. 3D Printing of paracetamol supposi-
tories: an automated manufacturing technique for individualized therapy. Pharmaceutics,
14(2022) 2676. https:// doi.org/ 10.3390/ pharma ceut ics1 4122 676
Dumpa, N., Butreddy, A., Wang, H., Komanduri, N., Bandari, S. and Repka, M.A. 3D printing
in personalized drug delivery: an overview of hot- melt extrusion- based fused deposition
modelling. International Journal of Pharmaceutics, 600 (2021) 120501.
Elkanayati, R.M., Chambliss, W.G., Omari, S., Almutairi, M., Repka, M.A. and Ashour, E.A.
Mucoadhesive buccal lms for treatment of xerostomia prepared by coupling HME and
https://t.me/med1917
20
Handbook of 3D Printing in Pharmaceutics
3D printing technologies. Journal of Drug Delivery Science and Technology, 75 (2022
Sep 1) 103660.
Elsayed, M., Ghazy, M., Youssef, Y. and Essa, K. Optimization of SLM process parameters for
Ti6Al4V medical implants. Rapid Prototyping Journal 25 (2019) 433– 447.
Eshkalak, S.K., Ghomi, E.R., Dai, Y., Choudhury, D. and Ramakrishna, S. The role of three-
dimensional printing in healthcare and medicine. Materials & Design, 194(2020) 10894.
https:// doi.org/ 10.1016/ j.mat des.2020.108 940
Fu, J., Yu, X. and Y. Jin. 3D printing of vaginal rings with personalized shapes for controlled
release of progesterone. International Journal of Pharmaceutics, 539 (2018) 75– 82.
Ganguli, A., Pagan- Diaz, G. J., Grant, L., Cvetkovic, C., Bramlet, M., Vozenilek, J., Kesavadas,
T. and Bashir, R. 3D printing for preoperative planning and surgical training: a review.
Biomedical Microdevices, 20(3)(2018) 65. https:// doi.org/ 10.1007/ s10 544- 018- 0301- 9
Gioumouxouzis, C.I., Katsamenis, O.L., Bouropoulos, N. and Fatouros D.G. 3D printed oral
solid dosage forms containing hydrochlorothiazide for controlled drug delivery. Journal
of Drug Delivery Science and Technology, 40(2017) 164– 171.
Greymi, T., Nicole, I., Essyrose, M., Aristides, D.T., Dimitrios, A.L. and Cynthia, Y.- W.-
M. 3D printing in ophthalmology: from medical implants to personalised medicine.
International Journal of Pharmaceutics, 625(2022), 122094.
Goyanes, A., Allahham, N., Treneld, S.J., Stoyanovd, E., Gaisford, S. and Basit, A.W. Direct
powder extrusion 3D printing: fabrication of drug products using a novel single- step process. International Journal of Pharmaceutics, 567 (2019) 118471.
Goyanes, A., Buanz, A.B. and Hatton, G.B. 3D printing of modied- release aminosalicylate (4-
ASA and 5- ASA) tablets. European Journal of Pharmaceutics and Biopharmaceutics,
89 (2015) 157– 162.
Goyanes, A., Chang, H. and Sedough, D. Fabrication of controlled- release budesonide tablets
via desktop (FDM) 3D printing. International Journal of Pharmaceutics, 496 (2015)
414– 420.
Goyanes, A., Det- Amornrat, U., Wang, J., Basit, A.W. and Gaisford, S. 3D scanning and 3D
printing as innovative technologies for fabricating personalized topical drug delivery
systems. Journal of Controlled Release, 234 (2016) 41– 48
Goyanes, A., Kobayashi, M. and Martínez- Pacheco, R. Fused- lament 3D printing of drug
products: microstructure analysis and drug release characteristics of PVA- based caplets.
International Journal of Pharmaceutics, 514 (2016) 290– 295.
Goyanes, A., Martinez, P. R., Buanz, A., Basit, A.W. and Gaisford, S. Effect of geometry
on drug release from 3D printed tablets. International Journal of Pharmaceutics, 494
(2015) 657– 663.
Gul, M., Arif, A. and Ghafoor, R. Role of three- dimensional printing in periodontal regener-
ation and repair: literature review. Journal of Indian Society of Periodontology, 33 (2019)
504– 510.
Hassanin, H., Finet, L., Cox, S.C., Jamshidi, P., Grover, L.M. and Shepherd, D.E.T. Tailoring
selective laser melting process for titanium drug- delivering implants with releasing
micro- channels. Additive Manufacturing, 20 (2018) 144– 155.
Hu, J., Fitaihi, R., Abukhamees, S. and Abdelhakim, H.E. Formulation and characterisation of
carbamazepine orodispersible 3D- printed mini- tablets for paediatric use. Pharmaceutics,
15(1) (2023) 250.
Hua, S. Physiological and pharmaceutical considerations for rectal drug formulations. Frontiers
in Pharmacology, 10 (2019) 1196.
Hua, S. Advances in oral drug delivery for regional targeting in the gastrointestinal tract-
inuence of physiological, pathophysiological and pharmaceutical factors. Frontiers in
Pharmacology, 28 (2020) 524.
https://t.me/med1917
Advancements in Tailoring Medication
Iliescu, F.S., Paunica, S., Vrtacnik, D. and Bobei, A.R. A double softlithography method for
21
processing of nono microneedles arrays. UPB Scientic Bulletin B: Chemistry and
Material Science, 79 (2017) 121– 132.
Ita, K. Transdermal delivery of drugs with microneedles- potential and challenges.
Pharmaceutics, 7 (2015) 90– 105.
Jamróz, W., Kurek, M. and Łyszczarz, E. 3D printed orodispersible lms with Aripiprazole.
International Journal of Pharmaceutics, 533 (2017) 413– 420.
Jamróz, W., Szafraniec, J. and Kurek, M. 3D printing in pharmaceutical and medical
applications – recent achievements and challenges. Pharmaceutical Research, 35
(2018) 176.
Jassim- Jaboori, A. and Oyewumi, M. 3D printing technology in pharmaceutical drug
delivery: prospects and challenges. Journal of Biomolecular Research & Нerapeutics,
4 (2015) 1– 3.
Jin, Z., He, C., Fu, J., Han, Q. and He, Y. Balancing the customization and standardiza-
tion: exploration and layout surrounding the regulation of the growing eld of 3D- printed
medical devices in China. Bio- design and Manufacturing, 5(2022) 580– 606.
Katakam, P., Adiki, S.K. and Satapathy, S.R. Recent advancements of additive manufacturing
for patient- specic drug delivery. In: Additive Manufacturing Processes in Biomedical
Engineering, 1st Edition. Boca Raton: CRC Press; (2022) 1– 26.
Keating, A.V., Soto, J., Tuleu, C., Forbes, C., Zhao, M. and Craig, D.Q.M. Solid state char-
acterisation and taste masking efciency evaluation of polymer based extrudates of isoniazid for paediatric administration. International Journal of Pharmaceutics, 536 (2018)
536– 546.
Kempin, W., Domsta, V., Grathoff, G., Brecht, I. Semmling, B., Tillmann, S., Weitschies,
W. and Seidlitz, A. Immediate release 3D- printed tablets produced via fused deposition
modeling of a thermo- sensitive drug. Pharmaceutical Research, 35 (2018) 124.
Khaled, S.A., Burley, J.C. and Alexander, M.R. Desktop 3D printing of controlled release
pharmaceutical bilayer tablets. International Journal of Pharmaceutics, 461
(2014)105– 111
Khaled, S.A., Burley, J.C., Alexander, M.R., Yang, J. and Roberts, C.J. 3D printing of tablets
containing multiple drugs with dened release proles. International Journal of
Pharmaceutics, 494(2) (2015) 643– 650.
Khan, F.B., Kilor, V., Sapkal, N. and Dule, P. Formulation development of mouth dissolving
printed lm of ketorolac and in vitro evaluation. International Journal of Applied
Pharmaceutics, 14(5) (2022) 128– 136.
Kumar, P., Vatsya, P., Rajnish, R.K., Hooda, A., and Dhillon, M.S. Application of 3D printing
in hip and knee arthroplasty: a narrative review. Indian Journal of Orthopaedics, 55
(2020) 14– 26. https:// doi.org/ 10.1007/ s43 465- 020- 00263- 8
Lei, L., Yu, Y., Ke, T., Sun, W. and Chen, L. The application of three- dimensional printing
model and platelet- rich brin technology in guided tissue regeneration surgery for severe
bone defects. Journal of Oral Implantology, 45 (2019) 35– 43.
Lewis, T. Could 3D printing solve the organ transplant shortage? The Guardian, 30 July (2017).
www.theg uard ian.com/ tec hnol ogy/ 2017/ jul/ 30/ will- 3d- print ing- solve- the- organ- tra nspl
ant- short age
Martinez, P.R., Goyanes, A. and Basit, A.W. Fabrication of drug- loaded hydrogels with
stereolithographic 3D printing. International Journal of Pharmaceutics, 532 (2017)
313– 317.
Mathew, E., Domínguez- Robles, J., Larrañeta, E. and Lamprou, D.A. Fused deposition model-
ling as a potential tool for antimicrobial dialysis catheters manufacturing: new trends vs.
conventional approaches. Coatings, 9(2019) 515.
https://t.me/med1917
22
Mathew, E., Pitzanti, G., Larrañeta, E. and Lamprou, D.A. 3D printing of pharmaceuticals and
Handbook of 3D Printing in Pharmaceutics
drug delivery devices. Pharmaceutics, 12(3) (2020) 266. https:// doi.org/ 10.3390/ pharma
ceut ics1 2030 266
McCoubrey, L.E., Favaron, A., Awad, A., Orlu, M., Gaisford, S. and Basit, A.W. Colonic drug
delivery: formulating the next generation of colon- targeted therapeutics. Journal of
Controlled Release, 1(2023) 1107– 1126.
Melocchi, A., Parietti, F., Maroni, A., Foppoli, A., Gazzaniga, A. and Zema, L. Hot- melt
extruded laments based on pharmaceutical grade polymers for 3D printing by fused
deposition modelling. International Journal of Pharmaceutics, 509 (2016) 255– 263.
Mohanty, S., Larsen, L.B., Trifol, J., Szabo, P., Burri, H.V.R. and Canali, C. Fabrication of scal-
able and structured tissue engineering scaffolds using water dissolvable sacricial 3D
printed moulds. Materials Science and Engineering, C, 55 (2015) 569– 578.
Musazzi, U.M., Selmin, F., Ortenzi, M.A., Mohammed, G.K., Franzé, S. and Minghetti, P.
Personalized orodispersible lms by hot melt ram extrusion 3D printing. International
Journal of Pharmaceutics, 551 (2018) 52– 59.
Muwaffak, Z., Goyanes, A., Clark, V., Basit, A.W., Hilton, S.T. and Gaisford, S. Patient-
specic 3D scanned and 3D printed antimicrobial polycaprolactone wound dressings.
International Journal of Pharmaceutics, 527 (2017) 161– 170.
Norman, J., Madurawe, R.D., Moore, C.M.V., Khan, M.A. and Khairuzzaman, A. A new
chapter in pharmaceutical manufacturing: 3Dprinted drug products. Advanced Drug
Delivery Reviews, 108 (2017) 39– 50.
Patel, A., Shah, T., Shah, G., Jha, V. and Ghosh, C. Preservation of bioavailability of ingredients
and lack of drug- drug interactions in a novel ve- ingredient polypill (Polycap ™).
American Journal of Cardiovascular Drugs, 10 (2012) 95– 103.
Patel, R., Sheth, T., Shah, S. and Shah, M. A new leap in periodontics: three- dimensional (3D)
printing. Journal of Advanced Oral Research, 8 (2017) 1– 7.
Pereira, B.C., Isreb, A., Forbes, R.T., Dores, F., Habashy, R. and J.B. Petit. Temporary
Plasticiser: a novel solution to fabricate 3D printed patient- centred cardiovascular ‘poly-
pill’ architectures. European Journal Pharmaceutics and Biopharmaceutics, 135 (2019)
94– 103.
Pieters, A., De Schrijver, H., Neefs, W. and Vertenten, W. 3D printing enables patient- specic
medical devices for a better quality of care. 2022.
Pietrzak, K., Isreb, A. and Alhnan, M.A. A exible- dose dispenser for immediate and extended
release 3D printed tablets. European Journal of Pharmaceutics and Biopharmaceutics,
96 (2015) 380– 387.
Point- of- Care 3D Solutions. 3dsystems.com. www.3dsyst ems.com/ hea lthc are/ point- of- care
Prasad, L.K. and Smyth, H. 3D printing technologies for drug delivery: a review. Drug
Development and Industrial Pharmacy, 42 (2016) 1019– 1031. doi: 10.3109/
03639045.2015.1120743
Pravin, S. and Sudhir, A. Integration of 3D printing with dosage forms: a new perspective for
modern healthcare. Biomedicine & Pharmacotherapy, 107 (2018) 146– 154.
Qian, H., Chen, D., Xu, X., Li, R., Yan, G. and Fan, T. FDM 3D- printed sustained- release
gastric- oating verapamil hydrochloride formulations with cylinder, capsule and hemi-
sphere shapes, and low inll percentage. Pharmaceutics, 14(2) (2022) 281.
Rasperini, G., Pilipchuk, S.P., Flanagan, C.L., Park, C.H., Pagni, G. and Hollister S.J. 3D-
printed bioresorbable scaffold for periodontal repair. Journal of Dental Research, 94
(2015) 153S– 157S.
Rengier, F., Mehndiratta, A., von Tengg- Kobligk, H., Zechmann, C.M., Unterhinninghofen, R.,
Kauczor, H.U. and Giesel, F.L. 3D printing based on imaging data: review of medical
https://t.me/med1917
Advancements in Tailoring Medication
23
applications. International Journal of Computer Assisted Radiology and Surgery, 5(4)
(2010) 335– 341. https:// doi.org/ 10.1007/ s11 548- 010- 0476- x
Rodríguez- Pombo, L., Martínez- Castro, L., Xu, X., On, J.J., Rial, C., García, D.N., González-
Santos, A., Flores- González, J., Alvarez- Lorenzo, C., Basit, A.W. and Goyanes, A.
Simultaneous fabrication of multiple tablets within seconds using tomographic volu-
metric 3D printing. International Journal of Pharmaceutics, 5 (2023) 100166.
Salmoria, G., Klauss, P. and Zepon. K. Development of functionally graded reservoir of
PCL/ PG by selective laser sintering for drug delivery devices: selective laser sintering-
fabricated drug delivery system that contains graded progesterone content. Virtual and
Physical Prototyping, 7 (2012) 107– 115.
Schweiger, J., Edelhoff, D. and Güth, J.F. 3D printing in digital prosthetic dentistry: an over-
view of recent developments in additive manufacturing. Journal of Clinical Medicine, 10
(2021): 2010. doi:10.3390/ jcm10092010
Serrano, D.R., Kara, A., Yuste, I., Luciano, F.C., Ongoren, B., Anaya, B.J. and Molina, G. 3D
printing technologies in personalized medicine, nanomedicines, and biopharmaceuticals.
Pharmaceutics, 15 (2023) 313. http:// dx.doi.org/ 10.3390/ pharma ceut ics1 5020 313
Serris, I., Serris, P., Frey, K.M. and Cho, H. Development of 3D- printed layered PLGA lms
for drug delivery and evaluation of drug release behaviours. AAPS PharmSciTech, 21
(2020) 1– 5.
Shkara, A.M. and Ghareeb, M.M. Formulation and in- vitro evaluation of rivaroxaban tablet
by fused deposition modelling 3d printing technique. International Journal of Drug
Delivery Technology, 12(1) (2022) 281– 291.
Singh, S., Vinchurkar, K., Dixit, P. and Mishra, D.k. Formulation design and evaluation of 3D
printed tablet of cinnarizine by fused deposition modeling technique. IJCRT, 9 (2021)
5881– 5897.
Skowyra, J., Pietrzak, K. and Alhnan, M.A. Fabrication of extended- release patient- tailored
prednisolone tablets via fused deposition modelling (FDM) 3D printing. European
Journal of Pharmaceutical Sciences, 68 (2015) 11– 17.
Solanki, N.G., Tahsin, M., Shah, A.V. and Serajuddin, A.T.M. Formulation of 3D printed
tablet for rapid drug release by fused deposition modeling: screening polymers for drug
release, drug polymer miscibility and printability. Journal of Pharmaceutical Sciences,
107 (2018) 390– 401.
Strianese, O., Rizzo, F., Ciccarelli, M., Galasso, G., D’Agostino, Y., Salvati, A., Del Giudice,
C., Tesorio, P. and Rusciano, M.R. Precision and personalized medicine: how genomic
approach improves the management of cardiovascular and neurodegenerative disease.
Genes, 11(7) (2020) 747. https:// doi.org/ 10.3390/ genes1 1070 747
Tagami, T., Yoshimura, N., Goto, E., Noda, T. and Ozeki, T. Fabrication of muco- adhesive
oral lms by the 3D printing of hydroxypropyl methylcellulose- based catechin- loaded
formulations. Biological and Pharmaceutical Bulletin, 42(11) (2019) 1898– 1905.
Tappa, K. and Jammalamadaka, U. Novel biomaterials used in medical 3D printing techniques.
Journal of Functional Biomaterials, 9 (2018) 17.
Turkyilmaz, I., and Wilkins, G. N. 3D printing in dentistry – exploring the new horizons. Journal
of Dental Ssciences, 16(3) (2021) 1037– 1038. https:// doi.org/ 10.1016/ j.jds.2021.04.004
Ursan, I.D., Chiu, L. and Pierce, A. Three- dimensional drug printing: a structured review.
Journal of the American Pharmacists Association, 53(2013) 136– 144.
Utomo, E., Domínguez- Robles, J., Anjani, Q.K., Picco, C.J., Korelidou A., Magee E.,
Donnelly, R.F. and Larrañeta, E. Development of 3D- printed vaginal devices containing
metronidazole for alternative bacterial vaginosis treatment. International Journal of
Pharmaceutics: X, 5(2022) 100142. doi: 10.1016/ j.ijpx.2022.100142
Соседние файлы в папке Библиотека им академика М.И. Перельмана